Related Experiment Video

Updated: May 8, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

Moving fecal microbiota transplantation into the mainstream

Robert Orenstein1, Cheryl L Griesbach, John K DiBaise

  • 1Robert Orenstein, Mayo Clinic, 5777 E Mayo Blvd, Phoenix, AZ 85054, USA.

Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition
|August 28, 2013
PubMed

Insights

Fecal microbiota transplantation (FMT) is increasingly used to treat recurrent Clostridium difficile infection (CDI). This article details FMT procedures, focusing on factors influencing its quality, safety, and patient outcomes for effective CDI management.

Area of Science:

  • Gastroenterology
  • Microbiology
  • Infectious Diseases

Background:

  • Clostridium difficile infection (CDI) affects nearly 600,000 individuals annually in the US.
  • An estimated 15,000 patients experience recurrent CDI, posing significant clinical challenges.
  • Recurrent CDI management remains difficult for both patients and healthcare providers.

Purpose of the Study:

  • To explore the resurgence of fecal microbiota transplantation (FMT) as a therapeutic option.
  • To describe the logistics and procedures involved in performing FMT.
  • To identify factors impacting FMT's quality, safety, and patient outcomes.

Main Methods:

  • Review of current literature on fecal microbiota transplantation (FMT) for recurrent Clostridium difficile infection (CDI).
  • Analysis of procedural logistics, including preparation and administration.
  • Examination of quality control, safety protocols, and outcome assessment in FMT.

Main Results:

  • Fecal microbiota transplantation (FMT) is an increasingly utilized and effective treatment for recurrent and refractory Clostridium difficile infection (CDI).
  • The article outlines the practical aspects of FMT procedures.
  • Key factors influencing the success, safety, and quality of FMT are discussed.

Conclusions:

  • Fecal microbiota transplantation (FMT) has reemerged as a practical and effective therapeutic modality for recurrent Clostridium difficile infection (CDI).
  • Understanding FMT logistics and quality/safety factors is crucial for successful patient outcomes.
  • FMT offers a viable solution for challenging recurrent CDI cases.
Keywords:
Clostridium difficile metagenomefecal microbiota transplantfecal transplantmicrobiome

More Related Videos

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

Related Concept Videos

Microbiota of the Large Intestine01:27

Microbiota of the Large Intestine

The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
What is Monogastric Digestion?01:50

What is Monogastric Digestion?

The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Functions of the Gut Microbiota01:18

Functions of the Gut Microbiota

The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...